Back

GLP1 agonists for obesity and diabetes.

3 December 2022 (13:00 - 13:20)
Organised by:
Congress Presentation Part of: Frontiers in cardiometabolic disease European Society of Cardiology ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Professor Junya Ako

Kitasato University School of Medicine, Sagamihara (Japan)

2 More presentations in this session

Presentation thumbnail
Lp(a) potential for treatment.
Professor S. Nicholls (Melbourne, AU)
Video
Presentation thumbnail
APSC Consensus statement on lipid management.
Doctor N. Koh (Singapore, SG)
Video

Access the full session

Session thumbnail
Frontiers in cardiometabolic disease
Video

The Event

Event poster

ESC Asia 2022 with APSC & AFC

3 December 2022 13:00 CET
You may be interested in
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
3 April 2025
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on blood pressure: a systematic review and meta-analysis
4 April 2025
thumbnail
Congress Presentation
GLP-1 RA vs DPP4i in patients with prior major adverse limb evets
30 August 2025
thumbnail
Congress Presentation
Percentage and main features of patients referred to a cardiac rehabilitation program who would have an indication for a GLP1 receptor agonist based on the SELECT trial criteria
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources